Peptide Medix product catalog

ELISA / EIA / RIA Kits · ELISA / EIA kit · Cat. EK-049-03

Neuropeptide Y (NPY) (Human, Rat, Mouse) – EIA Kit

Supplied as 96 wells per unit. Species: Human, Mouse, Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.

Specifications

Catalog numberEK-049-03
Product typeELISA / EIA / RIA Kits · ELISA / EIA kit
Peptide familyNeuropeptide Y (NPY)
SpeciesHuman, Mouse, Rat
Unit size96 wells
Sensitivity0.09 ng/ml
SpecificityPeptide % Neuropeptide Y (Human, Rat, Mouse) 100 Neuropeptide Y (Porcine) 100 Neuropeptide Y (3-36) (Human, Rat, Mouse) 14.3 Peptide YY (Human) 0 Peptide YY (Rat, Mouse, Porcine, Canine) 0 Pancreatic Polypeptide (Human) 0 VIP (Human, Rat, Porcine) 0 Insulin (Human) 0 Amylin (Human) 0 Somatostatin (Human, Rat, Mouse, Porcine) 0
Linear Range0.09 - 1.43 ng/ml
Inter-Assay CV<15%
Intra-Assay CV<10%
Standard CurveContact us for technical specifications on this product. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy. Sonmez FM, Zaman D, Aksoy A, et al. Seizure. 2013;22(10):856-61. Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts. Asea A, Kaur P, Panossian A, Wikman KG. Phytomedicine. 2013;20(14):1323-9. Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients. Buljevic S, Detel D, Pucar LB, et al. Rheumatol Int. 2013;33(11):2867-74. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors. Sitticharoon C, Chatree S, Churintaraphan M. Regul Pept. 2013;185:65-72. Weight gain in risperidone therapy: investigation of peripheral hypothalamic neurohormone levels in psychotic patients. Yanik T, Kursungoz C, Sutcigil L, Ak M. J Clin Psychopharmacol. 2013;33(5):608-13. The role of neuropeptide Y and aquaporin 4 in the pathogenesis of intestinal dysfunction caused by traumatic brain injury. Duan H, Hao C, Fan Y, et al. J Surg Res. 2013;184(2):1006-12. The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy. Ak M, Sezlev D, Sutcigil L, Akarsu S, Ozgen F, Yanik T. Psychoneuroendocrinology. 2013;38(3):341-7. Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea. Sánchez-de-la-torre M, Barceló A, Piérola J, et al. Respir Med. 2011;105(12):1954-60. Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density. Cawley NX, Yanik T, Woronowicz A, Chang W, Marini JC, Loh YP. Am J Physiol Endocrinol Metab. 2010;299(2):E189-97. Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. Rose JB, Crews L, Rockenstein E, et al. J Neurosci. 2009;29(4):1115-25. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. Yang K, Guan H, Arany E, Hill DJ, Cao X. FASEB J. 2008;22(7):2452-64. Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala. Cui H, Sakamoto H, Higashi S, Kawata M. Neuroscience. 2008;152(3):703-12. Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats. Lesniewska V, Rowland I, Cani PD, Neyrinck AM, Delzenne NM, Naughton PJ. Appl Environ Microbiol. 2006;72(10):6533-8. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder. Hou C, Jia F, Liu Y, Li L. Brain Res. 2006;1095(1):154-8. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Grimsholm O, Rantapää-dahlqvist S, Forsgren S. Arthritis Res Ther. 2005;7(3):R416-26. A high-yield method to extract peptides from rat brain tissue. Kline TR, Pang J, Hefta SA, Opiteck GJ, Kiefer SE, Scheffler JE. Anal Biochem. 2003;315(2):183-8.
Sample ExtractionRecommended
Intended useIn vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes

Frequently asked

What is Neuropeptide Y (NPY) (Human, Rat, Mouse) – EIA Kit?
Neuropeptide Y (NPY) (Human, Rat, Mouse) – EIA Kit is a elisa / eia kit elisa / eia / ria kit listed under catalog number EK-049-03 in the Neuropeptide Y (NPY) family, human / mouse / rat sequence. It is supplied as 96 wells per unit for in vitro laboratory research.
What is the intended use of EK-049-03?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.

This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.